Fosrenol (Avera McKennan Hospital)
Welcome to the PulseAid listing for the Fosrenol drug offered from Avera McKennan Hospital. This Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
NON-PROPRIETARY NAME: | lanthanum carbonate |
SUBSTANCE NAME: | LANTHANUM CARBONATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, CHEWABLE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-03-03 |
END MARKETING DATE: | 0000-00-00 |
Fosrenol HUMAN PRESCRIPTION DRUG Details:
Item Description | Fosrenol from Avera McKennan Hospital |
LABELER NAME: | Avera McKennan Hospital |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/1) |
START MARKETING DATE: | 2015-03-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69189-0252_97491ceb-a454-4419-ac85-1bd29d4c5a7f |
PRODUCT NDC: | 69189-0252 |
APPLICATION NUMBER: | NDA021468 |
Other LANTHANUM CARBONATE Pharmaceutical Manufacturers / Labelers: